You are here

  • Home
  • Archive
  • Volume 66, Issue Suppl 4
  • P113 The cost-effectiveness of step down from high dose fluticasone/salmeterol dry powder or suspension formulations in asthma applied to the UK setting

Citation Tools

Article menu

Download PDFPDF

Poster sessions
Managing asthma: inhaled therapy and beyond
P113 The cost-effectiveness of step down from high dose fluticasone/salmeterol dry powder or suspension formulations in asthma applied to the UK setting
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Paggiaro PL, Buseghin G, Nicolini G, et al
P113 The cost-effectiveness of step down from high dose fluticasone/salmeterol dry powder or suspension formulations in asthma applied to the UK setting
Thorax 2011;66:A113-A114.